Abiopharma

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

Adlai Nortye Announces $150.0 Million Private Placement Equity Financing

MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function

Canadian Premium Sand Inc. Announces Strategic Review

Perpetuals Announces Partnership with German University of Digital Science to License AI Trading Platform

Eshallgo Announces 1 for 16 Share Consolidation

Harrow Announces the Issuance of J-Code for IOPIDINE® 1%

Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting

Beasley Broadcast Group Extends Early Second Lien Tender Date, Exchange Offer Withdrawal Deadline, Tender Offer Expiration Date, First Lien Consent Solicitation Expiration Date, Exchange Offer Expiration Date, Tender Offer Settlement Date and the Exchange Offer Settlement Date of Previously Announced Exchange Offer and Tender Offer